Home » Business » “Samsung Chairman Lee Jae-yong Holds Meetings with Global Bio-Industry Leaders in the US”

“Samsung Chairman Lee Jae-yong Holds Meetings with Global Bio-Industry Leaders in the US”

photo-layout image photo_150627 max-width-600 float-center" data-idxno="150627" data-type="photo" style="display:inline-block">
Samsung Electronics Chairman Lee Jae-yong visited the US flagship Pioneering headquarters in November 2021.
Meeting with Moderna Co-Founder and Chairman of the Board, Noubar Afeyan [사진=삼성전자]

Samsung Electronics Chairman Lee Jae-yong held a series of meetings with global CEOs leading the bio market, including global Big Pharma and bio venture incubation companies, in the eastern United States, the world’s largest bio cluster.

Chairman Lee met ▲Joaquin Duato, CEO of J&J, ▲Giovanni Caporio, CEO of BMS, ▲Nuva Afejan Flagship Pioneering CEO, ▲Christopher Wiebacher, CEO of Biogen, and ▲Kevin Ali, CEO of Organon, to strengthen competitiveness in the bio business and discover new business opportunities for mutual cooperation. discussed.

▲J&J is a major customer of Samsung as a global top-tier biopharmaceutical company with a history of more than 140 years. .

As a co-founder of Moderna, Flagship CEO Nuba Afeyan contributed to overcoming the domestic corona crisis through an mRNA vaccine production contract with Samsung, and the two companies are also focusing on discovering and nurturing promising bio ventures, Samsung Electronics said.

In addition, Biogen established Samsung Bioepis through a joint venture with Samsung BioLogics, and sold all of its shares in Bioepis to Samsung last year. It’s an enterprise.

Samsung, which entered the bio business more than 10 years ago, has leaped to become the global No. 1 CDMO company through ▲quick decision-making and bold investment ▲preemption of future growth industries ▲overwhelming manufacturing technology through close collaboration with major partners.

Samsung Electronics said that Chairman Lee Jae-yong’s series of meetings with bio industry leaders was to foster the bio business as a ‘second semiconductor’ by further strengthening global collaboration across the bio industry.

Chairman Lee’s extensive global network is expected to serve as a ‘leverage’ for Samsung Bio’s business to expand collaboration with big pharmas and create future growth engines.

Meanwhile, after meeting with pharmaceutical companies, Chairman Lee Jae-yong met with employees of the North American sales office to check the current status of the global supply chain and encourage them.

Chairman Lee said, “The starting point is not important. A bold and persistent challenge determines victory or defeat.

Copyright © Pax Economy TV Unauthorized reproduction and redistribution prohibited

2023-05-07 08:24:21
#Chairman #Lee #Jaeyong #series #meetings #global #pharmaceutical #companies.. #Realization #2nd #Semiconductor #Myth #Spurred

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.